IMRIS Inc. has launched its HFD rocker arm for use in stabilizing patient’s heads during neurological procedures that use intraoperative imaging, following receipt of U.S. Food and Drug Administration 510(k) clearance. The device is intended for use with the company’s VISIUS surgical theatre.
VISIUS uses high-field intraoperative magnetic resonance imaging to give surgeons access to real-time diagnostic depictions of brain tissue, according to the Minneapolis, Minn., devicemaker. The scanner moves on ceiling-mounted rails to the desired position over the patient.
The rocker arm attaches to VISIUS’ clamp-like head fixation device, reducing pressure on the patient’s skull. The arm also allows the surgeon to stabilize, support and position heads with varying cranial anatomy, size and conditions, according to IMRIS."Providing these optimal tools for neurosurgeons will allow more patients to benefit from the value of diagnostic quality imaging in the operating room with VISIUS iMR," said Jay D. Miller, IMRIS president/CEO. "The development of the rocker arm is an example of products and features that allow neurosurgeons to use intraoperative MR inside the VISIUS Surgical Theater for an expanding patient population."
Inside a VISIUS Surgical Theater equipped with high-field intraoperative magnetic resonance imaging (iMRI), surgeons have on-demand access to real-time diagnostic quality imaging during the procedure and from the operating room table as the scanner moves to the patient on ceiling-mounted rails. The IMRIS head fixation devices (HFDs) limit patient movement or re-positioning and maintain optimal positioning for both surgical access and intraoperative imaging during neurosurgical procedures, the company claims.
The VISIUS iMRI gives neurosurgeons the ability to assess and decide to perform further resection for removing as much tumor as possible by clearly visualizing tumor and health brain tissue.
IMRIS develops image-guided therapy solutions through its VISIUS Surgical Theater, which serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets. The Theater is used by 61 medical institutions worldwide.